Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Microbiology & Infectious Diseases
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Europe Misses One in Five Tuberculosis Cases
March 2026
Tens of thousands of people remain undiagnosed while Europe’s multidrug-resistant tuberculosis rates are up to seven times the global average.
Read more
15 Apr 2025
ESCMID Global 2025: Breath-Based Bacterial Test Shows Real-Time Diagnostic Promise
A novel breath test that identifies bacterial infections may offer clinicians a rapid, non-invasive diagnostic and monitoring tool, according to findings presented at ESCMID Global 2025.
14 Apr 2025
ESCMID Global 2025: Three Million Child Deaths Tied to AMR in 2022
More than 3 million children worldwide died from antimicrobial resistance-related infections in 2022, according to a landmark study presented at ESCMID Global 2025.
13 Apr 2025
ESCMID Global 2025: RSV-Linked Respiratory Illness Nearly Triples Adult Mortality
Adults diagnosed with RSV-associated acute respiratory infection face nearly triple the risk of death within 1 year compared to their peers.
13 Apr 2025
ESCMID Global 2025: IL-6 Outperforms Traditional Tests for Early Sepsis Detection
A breakthrough study presented at ESCMID Global 2025 highlights IL-6 as a highly accurate early biomarker for sepsis in neonates, children, and pregnant women.
11 Apr 2025
Neonatal Antibiotics May Weaken Infant Vaccine Response
Early-life exposure to antibiotics may impair immune responses to routine infant vaccinations, according to new research.
9 Apr 2025
Delays in Sepsis Antibiotics Double Mortality Risk
Administering antibiotics more than 1 hour after emergency department presentation for suspected sepsis significantly increases the risk of 28-day in-hospital mortality.
7 Apr 2025
Capillary Lactate Predicts Sepsis Outcomes and Mortality
Capillary lactate levels strongly correlate with venous lactate and predict outcomes in patients with sepsis.
5 Apr 2025
Ensitrelvir Significantly Reduces COVID-19 Transmission in Households
Ensitrelvir reduces risk of COVID-19 in household contacts when administered within 72 hours of symptom onset.
Loading posts...
« Previous
1
…
19
20
21
22
23
…
44
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View